Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sagent Pharmaceuticals Inc (NASDAQ:SGNT)

14.49
Delayed Data
As of Feb 05
 -0.09 / -0.62%
Today’s Change
12.78
Today|||52-Week Range
30.75
-8.93%
Year-to-Date
No recent news for Sagent Pharmaceuticals Inc.

Today’s Trading

Previous close14.58
Today’s open14.50
Day’s range14.14 - 14.92
Volume522,459
Average volume (3 months)430,151
Market cap$475.1M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)+23.23%
Earnings growth (this year)-106.88%
Earnings growth (next 5 years)+4.76%
Revenue growth (last year)+18.07%
P/E ratio18.2
Price/Sales2.85
Price/Book1.68

Competitors

 Today’s
change
Today’s
% change
PDLIPDL BioPharma Inc+0.07+2.46%
AMPHAmphastar Pharmaceut...+0.03+0.27%
TGTXTG Therapeutics Inc-0.10-1.16%
COLLCollegium Pharmaceut...-0.52-2.70%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateFebruary 16, 2016
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$289.0M
Annual profit (last year)$39.9M
Net profit margin13.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Allan Oberman
President, Secretary &
Chief Legal Officer
Michael Logerfo
Corporate headquarters
Schaumburg, Illinois

Forecasts

Partner Offers